Financial Partners Group (Kansas)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,430
Closed -$213K 155
2022
Q1
$213K Sell
1,430
-391
-21% -$57.8K 0.05% 153
2021
Q4
$271K Sell
1,821
-350
-16% -$56.6K 0.06% 143
2021
Q3
$361K Sell
2,171
-219
-9% -$37.4K 0.09% 112
2021
Q2
$413K Sell
2,390
-5,556
-70% -$918K 0.11% 98
2021
Q1
$1.27M Buy
7,946
+270
+4% +$46.2K 0.36% 45
2020
Q4
$1.37M Sell
7,676
-237
-3% -$38.4K 0.41% 39
2020
Q3
$1.24M Sell
7,913
-373
-5% -$61K 0.43% 36
2020
Q2
$1.39M Sell
8,286
-766
-8% -$120K 0.54% 33
2020
Q1
$1.15M Buy
+9,052
New +$1.29M 0.71% 23

Other funds holding FBT

Financial Partners Group (Kansas)'s FBT Position: Q2 2022 in Review

Financial Partners Group (Kansas) sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2022, closing a stake of 1,430 shares — an estimated $213K sold.

Financial Partners Group (Kansas) first reported a position in FBT in Q1 2020 and held it in 9 quarters. The position peaked at $1.39M in Q2 2020. 223 funds tracked by Wall St. Rank hold FBT as of Q2 2022.

  • Financial Partners Group (Kansas) reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2022 after selling out during the quarter.
  • Financial Partners Group (Kansas) sold 1,430 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2022, an estimated $213K.
  • Financial Partners Group (Kansas) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2020 and held it in 9 quarters.
  • Financial Partners Group (Kansas)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.39M in Q2 2020.
  • 223 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2022.

Based on Financial Partners Group (Kansas)'s 13F filing for Q2 2022, filed 12 Aug 2022.